117 related articles for article (PubMed ID: 18053614)
21. Generation of carrier peptides for the delivery of nucleic acid drugs in primary cells.
Rennert R; Neundorf I; Jahnke HG; Suchowerskyj P; Dournaud P; Robitzki A; Beck-Sickinger AG
ChemMedChem; 2008 Feb; 3(2):241-53. PubMed ID: 18205166
[TBL] [Abstract][Full Text] [Related]
22. [Membrane permeable basic peptides: the potential of these peptides for the intracellular delivery of proteins and drugs].
Futaki S
Tanpakushitsu Kakusan Koso; 2002 Sep; 47(11):1415-9. PubMed ID: 12229209
[No Abstract] [Full Text] [Related]
23. Administration strategies for proteins and peptides.
Ibraheem D; Elaissari A; Fessi H
Int J Pharm; 2014 Dec; 477(1-2):578-89. PubMed ID: 25445533
[TBL] [Abstract][Full Text] [Related]
24. Intracellular protein delivery activity of peptides derived from insulin-like growth factor binding proteins 3 and 5.
Goda N; Tenno T; Inomata K; Shirakawa M; Tanaka T; Hiroaki H
Exp Cell Res; 2008 Aug; 314(13):2352-61. PubMed ID: 18602100
[TBL] [Abstract][Full Text] [Related]
25. Translocation or membrane disintegration? Implication of peptide-membrane interactions in pep-1 activity.
Henriques ST; Castanho MA
J Pept Sci; 2008 Apr; 14(4):482-7. PubMed ID: 18181239
[TBL] [Abstract][Full Text] [Related]
26. Gut instincts: explorations in intestinal physiology and drug delivery.
McConnell EL; Fadda HM; Basit AW
Int J Pharm; 2008 Dec; 364(2):213-26. PubMed ID: 18602774
[TBL] [Abstract][Full Text] [Related]
27. Peptide probes for protein transmembrane domains.
Slivka PF; Wong J; Caputo GA; Yin H
ACS Chem Biol; 2008 Jul; 3(7):402-11. PubMed ID: 18533658
[TBL] [Abstract][Full Text] [Related]
28. The augmentation of intracellular delivery of peptide therapeutics by artificial protein transduction domains.
Yoshikawa T; Sugita T; Mukai Y; Abe Y; Nakagawa S; Kamada H; Tsunoda S; Tsutsumi Y
Biomaterials; 2009 Jul; 30(19):3318-23. PubMed ID: 19304319
[TBL] [Abstract][Full Text] [Related]
29. Comparison of protein transduction domains in mediating cell delivery of a secreted CRE protein.
Shaw PA; Catchpole IR; Goddard CA; Colledge WH
Biochemistry; 2008 Jan; 47(4):1157-66. PubMed ID: 18179254
[TBL] [Abstract][Full Text] [Related]
30. Analysis of in vitro toxicity of five cell-penetrating peptides by metabolic profiling.
Kilk K; Mahlapuu R; Soomets U; Langel U
Toxicology; 2009 Nov; 265(3):87-95. PubMed ID: 19799958
[TBL] [Abstract][Full Text] [Related]
31. In vivo protein delivery to human liver-derived cells using hepatitis B virus envelope pre-S region.
Kasuya T; Yamada T; Uyeda A; Matsuzaki T; Okajima T; Tatematsu K; Tanizawa K; Kuroda S
J Biosci Bioeng; 2008 Jul; 106(1):99-102. PubMed ID: 18691539
[TBL] [Abstract][Full Text] [Related]
32. D-SAP: a new, noncytotoxic, and fully protease resistant cell-penetrating peptide.
Pujals S; Fernández-Carneado J; Ludevid MD; Giralt E
ChemMedChem; 2008 Feb; 3(2):296-301. PubMed ID: 18058782
[TBL] [Abstract][Full Text] [Related]
33. [PTD mediated protein transduction technology and its application in medical field].
Ye N; Lin Y; Pan J; Liu S; Rao P
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Apr; 28(2):401-4. PubMed ID: 21604510
[TBL] [Abstract][Full Text] [Related]
34. Efficient labeling of mesenchymal stem cells using cell permeable magnetic nanoparticles.
Suh JS; Lee JY; Choi YS; Yu F; Yang V; Lee SJ; Chung CP; Park YJ
Biochem Biophys Res Commun; 2009 Feb; 379(3):669-75. PubMed ID: 19101509
[TBL] [Abstract][Full Text] [Related]
35. Specific labeling with potent radiolabels alters the uptake of cell-penetrating peptides.
Walther C; Ott I; Gust R; Neundorf I
Biopolymers; 2009; 92(5):445-51. PubMed ID: 19399852
[TBL] [Abstract][Full Text] [Related]
36. Drug Delivery Systems--9th US-Japan symposium.
Uhland S
IDrugs; 2008 Mar; 11(3):186-8. PubMed ID: 18311655
[No Abstract] [Full Text] [Related]
37. Identification and design of peptides as a new drug delivery system for the brain.
Demeule M; Régina A; Ché C; Poirier J; Nguyen T; Gabathuler R; Castaigne JP; Béliveau R
J Pharmacol Exp Ther; 2008 Mar; 324(3):1064-72. PubMed ID: 18156463
[TBL] [Abstract][Full Text] [Related]
38. Targeting a c-Myc inhibitory polypeptide to specific intracellular compartments using cell penetrating peptides.
Bidwell GL; Davis AN; Raucher D
J Control Release; 2009 Apr; 135(1):2-10. PubMed ID: 19095020
[TBL] [Abstract][Full Text] [Related]
39. Dendritic cell acquisition of epitope cargo mediated by simple cationic peptide structures.
Chua BY; Eriksson EM; Poole DP; Zeng W; Jackson DC
Peptides; 2008 Jun; 29(6):881-90. PubMed ID: 18378356
[TBL] [Abstract][Full Text] [Related]
40. Transport molecules using reverse sequence HIV-Tat polypeptides: not just any old Tat? (WO200808225).
Howl J; Jones S
Expert Opin Ther Pat; 2009 Sep; 19(9):1329-33. PubMed ID: 19555160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
